Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Webber

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|December 1, 1994
Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitorD Raeburn, S L Underwood, S A Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activityM G Belvisi, S L Wicks, C H Battram, et al.
Journal of Medicinal Chemistry|March 19, 1993
Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinonesS E Webber, T M Bleckman, J Attard, et al.
Journal of Medicinal Chemistry|December 20, 1996
Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C proteaseS E Webber, J Tikhe, S T Worland, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acidsP S Dragovich, S E Webber, T J Prins, et al.
Journal of Medicinal Chemistry|July 21, 1998
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacementsS E Webber, K Okano, T L Little, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitorsS E Webber, J T Marakovits, P S Dragovich, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2000
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitorsP S Dragovich, R Zhou, S E Webber, et al.
Journal of Medicinal Chemistry|April 10, 1999
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacementsP S Dragovich, T J Prins, R Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 1999
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypesD A Matthews, P S Dragovich, S E Webber, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|December 1, 1994
Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitorD Raeburn, S L Underwood, S A Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activityM G Belvisi, S L Wicks, C H Battram, et al.
Journal of Medicinal Chemistry|March 19, 1993
Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinonesS E Webber, T M Bleckman, J Attard, et al.
Journal of Medicinal Chemistry|December 20, 1996
Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C proteaseS E Webber, J Tikhe, S T Worland, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acidsP S Dragovich, S E Webber, T J Prins, et al.
Journal of Medicinal Chemistry|July 21, 1998
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacementsS E Webber, K Okano, T L Little, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitorsS E Webber, J T Marakovits, P S Dragovich, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2000
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitorsP S Dragovich, R Zhou, S E Webber, et al.
Journal of Medicinal Chemistry|April 10, 1999
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacementsP S Dragovich, T J Prins, R Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 1999
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypesD A Matthews, P S Dragovich, S E Webber, et al.
Pageof 9